Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy
Value Health
.
2014 Nov;17(7):A624.
doi: 10.1016/j.jval.2014.08.2218.
Epub 2014 Oct 26.
Authors
M M Kruse
1
,
R Wildner
1
,
G Barnes
2
,
M Martin
3
,
U Mueller
4
,
F Lo Coco
5
,
S Leyman
6
,
A Pathak
2
Affiliations
1
Optum, Waltham, MA, USA.
2
Teva Pharmaceutical, 19355, PA, USA.
3
OptumInsight, Uxbridge, Middlesex, UK.
4
Teva Pharmaceutical, Ehrenkirchen, Germany.
5
University Tor Vergata, Rome, PA, USA.
6
TEVA Pharmaceuticals Europe, Amsterdam, The Netherlands.
PMID:
27202202
DOI:
10.1016/j.jval.2014.08.2218
No abstract available